Orthovita’s Vitoss scaffolds are marketed specifically for the purpose of providing non-load bearing geometric support during new tissue growth. Aastrom’s tissue repair cells (TRCs), meanwhile, are a mixture
The trial, named RESPOND, will investigate the use of a multipurpose biomarker, Protein C, to be used in connection with the administration of Xigris (drotrecogin alfa [activated]). Under
Orphan drug designation could provide SciClone with seven years of market exclusivity in the US should Zadaxin receive regulatory approval from the FDA for the treatment of malignant
The company said that it will continue to work with FDA to resolve outstanding issues including product labeling and post marketing commitments. In August, the FDA issued an
The completion of enrollment keeps the company on course to report data from this trial during 2006. Antisoma is currently conducting three separate phase II trials with AS1404
The company’s scientists found that these adult stem cells were able to differentiate into most tissues and organs of the body – including spermatogonia. The company further said
The trial was evaluating temsirolimus in combination with Femara, Novartis’ currently approved breast cancer therapy. The study compared the combination of the drugs versus Femara alone. This decision
Ceflatonin is the first of a new class of novel drugs that induces programmed cell death and inhibits the formation of new blood vessels that support the tumor.
The company said that initial activity will commence in such areas as addiction, cognition, anxiety, depression and stress-related disorders, but is expected to include several other disease areas.
Yaz has a dosing regimen of 24 days of active hormone pills and four days of placebo, reducing the typical monthly hormonal fluctuations compared to traditional oral contraceptives
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.